PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 165 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2015. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $358,000 | +18.2% | 7,804 | +52.2% | 0.00% | 0.0% |
| Q2 2018 | $303,000 | +13.1% | 5,129 | +30.1% | 0.00% | 0.0% |
| Q1 2018 | $268,000 | -10.1% | 3,941 | +30.5% | 0.00% | 0.0% |
| Q4 2017 | $298,000 | +0.3% | 3,019 | +21.8% | 0.00% | 0.0% |
| Q3 2017 | $297,000 | +18.8% | 2,478 | -13.4% | 0.00% | 0.0% |
| Q2 2017 | $250,000 | +278.8% | 2,862 | +62.3% | 0.00% | – |
| Q1 2017 | $66,000 | +32.0% | 1,763 | +7.6% | 0.00% | – |
| Q4 2016 | $50,000 | -35.9% | 1,638 | +41.5% | 0.00% | – |
| Q3 2016 | $78,000 | +680.0% | 1,158 | +258.5% | 0.00% | – |
| Q2 2016 | $10,000 | +42.9% | 323 | +44.8% | 0.00% | – |
| Q1 2016 | $7,000 | -58.8% | 223 | 0.0% | 0.00% | – |
| Q4 2015 | $17,000 | 0.0% | 223 | 0.0% | 0.00% | – |
| Q3 2015 | $17,000 | -67.9% | 223 | 0.0% | 0.00% | – |
| Q1 2015 | $53,000 | +26.2% | 223 | 0.0% | 0.00% | – |
| Q4 2014 | $42,000 | – | 223 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avalon Global Asset Management LLC | 30,000 | $3,503,000 | 2.29% |
| WEATHERBIE CAPITAL, LLC | 141,123 | $16,476,000 | 1.67% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $663,918,000 | 1.66% |
| BB BIOTECH AG | 521,991 | $60,942,000 | 1.65% |
| CORNERSTONE CAPITAL MANAGEMENT LLC | 317,032 | $37,013,000 | 1.21% |
| Orbimed Advisors | 940,800 | $109,838,000 | 0.81% |
| Perceptive Advisors | 100,000 | $11,675,000 | 0.70% |
| Ghost Tree Capital, LLC | 17,500 | $2,043,000 | 0.66% |
| CAPITAL INTERNATIONAL LTD /CA/ | 90,935 | $10,617,000 | 0.63% |
| Fernwood Investment Management, LLC | 6,800 | $794,000 | 0.62% |